These data provide a strong rationale for future studies examining the role of lead in the regulation of cadherin/catenin and MMP-9 expression, and the role of cadmium in the E- to n-cadherin switch in RCC, as well as the aberrant expression of p120-catenin. This evidence concerns the gene CDH17 and renal cell carcinoma.